This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Animal Model Development
Introduction
BioVenic's Non-GLP Animal Model Development & In Vivo Services provide a robust bridge from hypothesis to data. We can help you speed up your research process by combining cutting-edge induction methods with strict phenotypic validation and downstream bioanalysis. We provide high-quality, customized models and actionable data that help your drug discovery and mechanism studies move forward with scientific confidence and operational efficiency.
Our Services
Bespoke Animal Model Development
BioVenic specializes in creating highly translational models tailored to your specific research objectives. Beyond standard offerings, we provide custom development using diverse induction methods. We work with a wide range of species, including rodents, rabbits, and canines, optimizing strain and age to match your experimental requirements.
Table. 1 BioVenic Animal Model Development Services (by Inducing Methods)
Table. 2 BioVenic Animal Model Development Services (by Research Areas)
Comprehensive Model Validation & Characterization Services
To ensure the reliability of your results, BioVenic perform multi-dimensional validation to confirm successful model establishment. Our team uses the most advanced platforms to do thorough phenotypic characterization. We give you the final proof-of-concept you need before you start therapeutic screening by linking clinical signs to molecular markers.
- Animal Behavioral Analysis
- Animal Histopathology Service
- Preclinical Animal Pharmacodynamics (PD) Study
- Preclinical Animal Pharmacokinetics (PK) Study
- Animal Cell Biology Service
- Animal lmaging Service
Specialized Specimen Collection Services
Precision in downstream analysis starts with expert sampling. BioVenic offers comprehensive animal tissue, cell, and fluid collection services, including the harvesting of blood, primary cells, and specific organs. Samples can be processed immediately for markers, flash-frozen, or paraffin-embedded, then shipped to your facility or transferred to our internal labs for further analysis.
Downstream Experimental Research on Animal Models
Our facility is equipped to execute a variety of downstream applications on established models. BioVenic provides Pharmacokinetics (PK) studies to evaluate compound distribution and Pharmacodynamics (PD) studies to assess biological efficacy. Additionally, we conduct preliminary safety assessments, dose-response profiling, and biomarker discovery (via qPCR, Western Blot, or ELISA) to provide a holistic view of your candidate's performance in a living system.
Development Workflow for an Animal Model
Our Deliverables: Translational Data & High-Value Biospecimens
At BioVenic, we turn complicated animal model development into useful research tools. Instead of sending you live animals, we send you a complete data and specimen package that serves as the final Proof-of-Concept for your therapeutic candidates. Here are the things we usually deliver:
- Comprehensive Model Validation Report: A full scientific report that includes the custom induction process (genomic, chemical, surgical, etc.), clinical observations, and statistical proof that the disease modeling worked.
-
Data on Multiple Dimensions of Phenotypes:
Histopathology Suite: Digital images with high resolution and expert scoring for H&E, IHC, and special staining.
Molecular Characterization: Quantitative analysis of biomarkers through qPCR, Western Blot, or ELISA, establishing correlations between clinical manifestations and molecular signatures.
Functional Insights: Comprehensive outcomes from behavioral analysis and in vivo imaging, offering a complete perspective of the model's pathophysiology.
- Pharmacokinetics (PK) and Pharmacodynamics (PD) Profiling: Exact information on how a compound spreads, how stable it is in the body, and how well it works.
-
Specialized Biological Specimens: Materials that have been carefully harvested and processed to meet your specific needs, such as:
Isolated Primary Cells: Animal cells that are very pure or cell lines that have been around for a long time.
Processed Tissues: Samples given as flash-frozen, formalin-fixed, or paraffin-embedded (FFPE) blocks or slides.
Biofluids: Blood, serum, or other specific physiological fluids that have been expertly collected.
- Customized Raw Data Sets: You have full access to all of the raw experimental data, which makes sure that everything is clear and ready for your internal R&D reviews or future regulatory filings.
Case Study
Recent case studies in exploratory pharmacology highlight the strategic significance of non-GLP frameworks; for example, utilizing syngeneic mouse models to swiftly assess the dose-dependent anti-tumor efficacy of novel immunotherapies, or employing chemically-induced models (such as TNBS-induced IBD or ACLT-induced osteoarthritis) to confirm disease-modifying potential with expedited turnaround times. Our non-GLP animal model development approach is more flexible than strict GLP protocols. It lets us make changes to study designs, dosing, and biomarkers in real time, which gives us high-quality, translational data. BioVenic helps researchers optimize formulations and confirm Proof-of-Concept (PoC) with confidence by filling in the gap between the initial idea and IND-enabling studies. This makes sure that only the best candidates move forward in the development pipeline.
Fig 1. Histopathological Features in TNBS-Induced Colitis in Mice1
Advantages of BioVenic Animal Model Development Service
Diverse Methodologies:
We combine genomic, chemical, dietary, and surgical techniques to build highly specific models. BioVenic experts help you navigate the pros and cons of each induction method to find the "Goldilocks" solution for your study.
Scientific Customization:
Every project is unique. We tailor protocols based on your preliminary data and target goals, ensuring the animal model is fit-for-purpose rather than a "one-size-fits-all" approach.
Integrated One-Stop Service:
From the initial IACUC filing to the final bioarchiving of tissues, we manage the entire lifecycle. This integration reduces lead times and eliminates the logistical risks of moving animals or samples between multiple vendors.
FAQs
Q: Can you work with client-provided test articles or specific strains?
A: Yes. We can either source animals and reagents for you or receive your proprietary compounds and specialized strains. We maintain strict material receipt records and storage conditions.
Q: Is your facility compliant with animal welfare standards?
A: We prioritize animal welfare and operate under an IACUC-monitored system, ensuring all procedures meet ethical standards for non-GLP preclinical research.
Q: Do you provide BSL-2 pathogen challenge models?
A: Currently, our facilities are optimized for non-infectious disease models and do not support BSL-2 level pathogen studies. We focus on chemical, surgical, and genetic induction methods.
Contact Us
Speed up your preclinical discovery by working with someone who knows the ins and outs of animal physiology and how to do experiments correctly. Our team is ready to provide you with high-quality data that will help your project move forward, whether you need a pilot study for a new target or a large-scale efficacy screen. Contact our scientific team today for a technical consultation and a customized quote tailored to your research needs.
References
- Silva, I., et al. "Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease." Int. J. Mol. Sci. 23(2022), 4739. https://doi.org/10.3390/ijms23094739. Distributed under Open Access license CC BY 4.0. The original title of the figure was changed to "Histopathological Features in TNBS-Induced Colitis in Mice".